Genetic Technologies (ASX:GTG) has initiated a trading halt on its securities starting 17 October 2024. This pause is to evaluate strategic options, conduct an operational review, and update on fundraising progress announced in July 2024. The halt is expected to last until 21 October 2024 or an earlier announcement.
Genetic Technologies (ASX:GTG) has requested a trading halt effective from 17 October 2024. This halt is a strategic decision aimed at assessing the company's strategic options and conducting an operational review. Additionally, it is linked to the company's fundraising efforts initiated in July 2024. The halt is set to continue until either an announcement is made or until the commencement of trading on 21 October 2024. The company has communicated this decision formally to the ASX and plans to update the market with relevant information before trading resumes. This move reflects the company's proactive approach to maintaining transparency and ensuring strategic alignment with its goals.
The trading halt will enable Genetic Technologies to thoroughly assess its strategic options and operational efficiencies. We are committed to updating the market in a timely manner.